OBJECTIVE: To examine the association between the sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer. METHOD: Meta-analysis of case-control studies using a random effects model. The "Main outcome measure" was the odds ratio for the risk of lung cancer, using extensive metabolisers as the reference group. RESULTS: Thirteen studies were identified. The studies were too heterogeneous to be pooled the size of the odds ratio increased with the sample size. When the analysis was restricted to the largest studies, there was no difference in risk between poor and extensive metabolisers (odds ratio 0.95, 95% confidence interval 0.68-1.33). CONCLUSION: No association was found between the CYP2D6 oxidation polymorphism and lung cancer risk when sample size bias was taken into account.
OBJECTIVE: To examine the association between the sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer. METHOD: Meta-analysis of case-control studies using a random effects model. The "Main outcome measure" was the odds ratio for the risk of lung cancer, using extensive metabolisers as the reference group. RESULTS: Thirteen studies were identified. The studies were too heterogeneous to be pooled the size of the odds ratio increased with the sample size. When the analysis was restricted to the largest studies, there was no difference in risk between poor and extensive metabolisers (odds ratio 0.95, 95% confidence interval 0.68-1.33). CONCLUSION: No association was found between the CYP2D6 oxidation polymorphism and lung cancer risk when sample size bias was taken into account.
Authors: I Stücker; J Cosme; P Laurent; S Cenée; P Beaune; J Bignon; A Depierre; B Milleron; D Hémon Journal: Carcinogenesis Date: 1995-11 Impact factor: 4.944
Authors: N E Caporaso; M A Tucker; R N Hoover; R B Hayes; L W Pickle; H J Issaq; G M Muschik; L Green-Gallo; D Buivys; S Aisner Journal: J Natl Cancer Inst Date: 1990-08-01 Impact factor: 13.506
Authors: P Mota; H C Silva; M J Soares; A Pego; M Loureiro; C Robalo Cordeiro; F J Regateiro Journal: J Cancer Res Clin Oncol Date: 2014-11-12 Impact factor: 4.553
Authors: Sylviane de Viron; Johan Van der Heyden; Elena Ambrosino; Marc Arbyn; Angela Brand; Herman Van Oyen Journal: PLoS One Date: 2012-07-11 Impact factor: 3.240